Table 2.
Reported Frequency of Primary Care Physicians’ Treatment Recommendations for a Patient with Symptoms Suggestive of IC/PBS* (n= 239)
| Antibiotics | |
| Almost all | 18% |
| More than half | 14% |
| About half | 10% |
| Less than half | 12% |
| Very few | 23% |
| None | 24% |
| Nonsteroidal anti-inflammatory medications | |
| Almost all | 10% |
| More than half | 24% |
| About half | 15% |
| Less than half | 16% |
| Very few | 15% |
| None | 21% |
| Anti-depressant medications | |
| Almost all | 3% |
| More than half | 8% |
| About half | 12% |
| Less than half | 24% |
| Very few | 25% |
| None | 29% |
| Anticholinergics (e.g., oxybutynin) | |
| Almost all | 7% |
| More than half | 20% |
| About half | 20% |
| Less than half | 15% |
| Very few | 21% |
| None | 17% |
| Bladder analgesics (e.g., pyridium) | |
| Almost all | 4% |
| More than half | 11% |
| About half | 16% |
| Less than half | 15% |
| Very few | 26% |
| None | 28% |
| Pentosan polysulfate (Elmiron®) | |
| Almost all | 2% |
| More than half | 2% |
| About half | 1% |
| Less than half | 5% |
| Very few | 16% |
| None | 75% |
| Antihistamines | |
| Almost all | 1% |
| More than half | 0% |
| About half | 1% |
| Less than half | 3% |
| Very few | 16% |
| None | 79% |
| Narcotic pain medications | |
| Almost all | 0% |
| More than half | 1% |
| About half | 1% |
| Less than half | 5% |
| Very few | 26% |
| None | 68% |
| Complementary/ alternative medicine therapies | |
| Almost All | 1% |
| More than half | 2% |
| About half | 7% |
| Less than half | 11% |
| Very few | 25% |
| None | 54% |
| Anticonvulsants (e.g., Neurontin®) | |
| Almost all | 0% |
| More than half | 1% |
| About half | 1% |
| Less than half | 5% |
| Very few | 26% |
| None | 68% |
| Other | |
| Yes | 4% |
| No | 96% |
*
Interstitial Cystitis / Painful Bladder Syndrome